levbrans

Author Archives

Recent Author Comments

On The Twelve Biotechs of Christmas 2018: Balthasar

$?tcker $vtgn Doc do you by chance remeber the company you talked about a while back (couple months) that was doing the royalty model for private mom and pop, traditionally not financed companies? It was from that conference when you did the private compan[...]

Go to Comment »
On The Twelve Biotechs of Christmas 2018: Balthasar

$noticker Dan please spare us your eloquent use of the English language. Your fascinating dialogue and outlook on life have reached such a level to which we at his forum would not dare hold you back from reaching new heights of literary achievement on your[...]

Go to Comment »
On The Twelve Biotechs of Christmas 2018: Balthasar

Not that Doc and the knowledge gained here are not certainly worth $1000 or whatever the new price is, but members of lesser means ( like myself ) would have to be removed from the service. That expense would be a non-trivial proportion of my portfolio. Wh[...]

Go to Comment »
On Annual Review: This Week's Updates, Disney, Five Below, JD.com and Options Speculations

Sounds like diebold[...]

Go to Comment »
On The Twelve Biotechs of Christmas 2018: Balthasar

$Cleveland, $arth - you all are so funny. Numbers don't lie, if your model doesn't fit the truth... just keep staying with it right. HAha... You would have also missed the 130% gain this year in APTO if you waited tell the tutes got the easy money and sold[...]

Go to Comment »
On The Twelve Biotechs of Christmas 2018: Balthasar

why am I looking @ BLPH 8k's at 2 am.... anyways, looks like all important people got 20,000-50000 options. Explains why we saw some slight selling of positions. They knew this years bonus was coming. Always good to see the' A' and not the 'D' though, a[...]

Go to Comment »
On Dr. KSS Posts from Biotech Showcase 2018, San Francisco

Take some much needed time off Doc. Your work ethic is utterly remarkable and you have been pumping out so much awesome material from the conference. Thanks so much for the tireless work you put in for the good of the everyday investor. The Robinhood of Bi[...]

Go to Comment »
On The Twelve Biotechs of Christmas 2018: Balthasar

$HALO - Thanks Doc for the clarity on HALO, glad I was able to catch that today. Started noting some weird activity afterhours, hope we were able to save some people some money. Currently my position is in a few aggressive options. Didnt have more in the[...]

Go to Comment »
On The Twelve Biotechs of Christmas 2018: Balthasar

$HALO - https://t.co/kVuXZKTEFU Hope that link works anyways, HALO taking a big hit in after hours "$HALO SWOG S1313 full data out in #GI18 abstract abstracts.asco.org/210/AbstView_2… whoa PEGPH20 + mFFOX did much much worse than mFFOX alone. [...]

Go to Comment »
On Dr. KSS Posts from Biotech Showcase 2018, San Francisco

Simply outstanding! LOVE this from commentary from Patrick Lin. One of the best things I have read this month and added the comment to my Bio Investing folder so I can refer to it often. Doc, thanks for putting in the hard work to be @ these conferences fo[...]

Go to Comment »
On Dispelling Certain Aurinia ($AUPH) Rumors

Lets not act so entitled. Doc has repeadly hinted there are better place to have money for near term gains than CLRB. Maintaining his relationship with the CEO is significantly more important.[...]

Go to Comment »
On Dispelling Certain Aurinia ($AUPH) Rumors

Coyote - if you have a twitter, give me a follow @ levbrans. I want to throw something by you.[...]

Go to Comment »
On Dispelling Certain Aurinia ($AUPH) Rumors

Wanted to relay some interesting biotech quotes by Klendathu Capitalist "Compounding the undervalued nature of the sector, most fund flows are going into flawed immuno and gene therapies. Example: Gene therapy co targets ~13% of patient pop has 100x va[...]

Go to Comment »
On Microblog: Gold, Silver, Copper, and Hard Assets…Fall 2017

talked to a major hedge fund guy in the natural resources space over the weekend different commodities and equities within the space. Sama is his #1 2018 idea he is looking at. VERY asymmetric @ this valuation and with HPX on board this has massive ups[...]

Go to Comment »
On Is a Misperception Subduing Share Price at Aptose ($APTO)?

Haha, you do have a way with words and teaching Doc! Thanks so much for the AKTX commentary. I closed my position @ even and it's with AUPH & ARTH in the invest in 6-18 months basket. Don't want to be waiting so long for the L-conversion to start being fa[...]

Go to Comment »
On Special Comment: Update from $ARTH CEO Terrence Norchi, MD, MBA

AKTX - Listened to the webcast as well. All comments on data Ive seen on twitter and other sources have been bullish so far. Tomorrow could be a fun one! Several analyst's in the audience who don't currently "follow" aktx, so we could see some new rating[...]

Go to Comment »
On Special Comment: Update from $ARTH CEO Terrence Norchi, MD, MBA

Was reading twitter and saw and interesting tid bit, this Alexion collaboration w/ HALO will give its PNH drug even more competitive advantage over AKTX's Coversine of which I am long due to switching from IV to subcut. Still market cap difference of $22 b[...]

Go to Comment »
On Special Comment: Update from $ARTH CEO Terrence Norchi, MD, MBA

Thanks Ben, this TRIL filling is interesting. This is held by David Goel of Matrix Capitol Management who is in the lineage of Julian Robertson 2.17 mil share or a 14% stake I believe. Big buy! This guy holds under 20 positions in his fund usually. On[...]

Go to Comment »
On Special Comment: Update from $ARTH CEO Terrence Norchi, MD, MBA

On AKTX and Baby ontologies - sounds good Dr KSS, cant wait to read your reply.[...]

Go to Comment »
On Special Comment: Update from $ARTH CEO Terrence Norchi, MD, MBA

THIS IS A REPOST FROM THE TERRY HILLS THREAD (sorry if you already saw this Doc but it posted right as we moved here so figured you might not have) - $AKTX - Doc I was going to ask this on the CC but didn’t want to tire you out too much. This is my 3[...]

Go to Comment »

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info